Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Takeda Pharma (TKPYY)

Takeda Pharma (TKPYY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 25,919,552
  • Shares Outstanding, K 1,562,360
  • Annual Sales, $ 15,935 M
  • Annual Income, $ 1,682 M
  • 60-Month Beta 0.42
  • Price/Sales 1.64
  • Price/Cash Flow N/A
  • Price/Book 1.36
Trade TKPYY with:
  • Price/Earnings ttm 12.22
  • Earnings Per Share ttm 1.37
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/07/19
  • Annual Dividend & Yield 0.58 (3.48%)
  • Most Recent Dividend 0.288 on 09/27/18
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.5000 +7.03%
on 12/18/18
19.2300 -13.73%
on 11/26/18
-2.6300 (-13.68%)
since 11/21/18
3-Month
15.5000 +7.03%
on 12/18/18
21.9399 -24.38%
on 09/26/18
-4.3650 (-20.83%)
since 09/21/18
52-Week
15.5000 +7.03%
on 12/18/18
31.2900 -46.98%
on 02/01/18
-11.8100 (-41.58%)
since 12/21/17

Most Recent Stories

More News
Mucopolysaccharidosis Treatment Market to Exhibit a CAGR of 10.4% and Hit USD 4.37 Billion by 2026; Growing Cases of Rare Diseases to Spur Business Opportunities, states Fortune Business Insights(TM)

The global mucopolysaccharidosis treatment market size is predicted to reach USD 4.37 billion by 2026, exhibiting a CAGR of 10.4% during the forecast period. The growing cases of rare diseases can be critical...

RGNX : 37.05 (+3.93%)
TKPYY : 16.5900 (-0.90%)
Cancer/Tumor Profiling Market Development, Future Trends and Indepth Analysis Research | Illumina Inc, Qiagen N.V.

A consciously conceived and designed business intelligence report titled Global  by Manufacturers, Type, and Application, Forecast to 2029 by discloses a succinct analysis of the regional spectrum,...

AGCO : 93.46 (+0.28%)
GHDX : 63.44 (-0.69%)
HTGM : 4.71 (+0.43%)
ILMN : 317.03 (+4.29%)
QGEN : 48.49 (+2.62%)
RTN : 116.70 (-0.22%)
TKPYY : 16.5900 (-0.90%)
VRX.TO : 30.80 (-3.33%)
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the collaboration and license agreement between Arrowhead and Takeda Pharmaceutical Company Limited announced on October 8, 2020, has...

TKPYY : 16.5900 (-0.90%)
ARWR : 62.99 (+10.47%)
Global Dengue Vaccines Market to Cross USD 1100 Million by 2027; Asia Pacific to Hold Leading Market Share with China Dengue Vaccines Market Touching Nearly USD 140 Million by 2027

Also known as breakbone or dandy fever, the total number of recorded dengue fever cases across the globe were around 1.5 million by the middle of 2020. Co-infection of dengue and COVID-19 is raising complications,...

GSK : 37.07 (-0.43%)
TKPYY : 16.5900 (-0.90%)
High-K And ALD/CVD Metal Precursors Market Predicted To Accelerate The Growth by 2020-2029 Cover Covid-19 Pandemic Impact | Air Liquide S.A., Air Products & Chemicals

A consciously conceived and designed business intelligence report titled Global  by Manufacturers, Type, and Application, Forecast to 2029 by discloses a succinct analysis of the regional spectrum,...

ARHUF : 18.7016 (+3.67%)
AIQUY : 33.0050 (+1.77%)
GEAGF : 37.3000 (+6.27%)
JSCPF : 15.5000 (unch)
TKPYY : 16.5900 (-0.90%)
VRX.TO : 30.80 (-3.33%)
Constipation Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis

, /PRNewswire/ -- The report has been added to offering.

ABBV : 104.89 (+0.66%)
ALBO : 36.31 (-1.73%)
BAYRY : 14.8620 (+1.38%)
TKPYY : 16.5900 (-0.90%)
XOMA Earns $2 Million Milestone from Takeda as Mezagitamab Advances into Phase 2 Development

XOMA Corporation (Nasdaq: XOMA) ("XOMA" or the "Company") today announced it has earned a $2 million milestone payment from Takeda Pharmaceutical Company Limited as the first patient has been dosed in...

TKPYY : 16.5900 (-0.90%)
XOMA : 32.05 (-1.87%)
Chromium Trioxide Market huge growth, Key Methodologies and Top Players With CAGR 1.30% | Thermo Fisher Scientific, Inc.

A consciously conceived and designed business intelligence report titled Global  by Manufacturers, Type, and Application, Forecast to 2029 by  discloses a succinct analysis of the regional spectrum,...

ARHUF : 18.7016 (+3.67%)
GEAGF : 37.3000 (+6.27%)
MKKGY : 31.9400 (+3.43%)
TKPYY : 16.5900 (-0.90%)
VRX.TO : 30.80 (-3.33%)
Final Results from the Phase 3 HELP Study(TM) Open-Label Extension Support TAKHZYRO(R) (lanadelumab-flyo) Injection as a Long-term Preventive Treatment Option in Patients with Hereditary Angioedema

--Data Presented at the 2020 American College of Allergy, Asthma and Immunology Virtual Annual Scientific Meeting

TKPYY : 16.5900 (-0.90%)
TAK : 17.97 (+1.41%)
OrigiMed and Takeda Announced Partnership to Accelerate R&D and Commercialization of Innovative Medicines

TKPYY : 16.5900 (-0.90%)

Key Turning Points

2nd Resistance Point 17.1900
1st Resistance Point 16.8900
Last Price 16.5900
1st Support Level 16.3200
2nd Support Level 16.0500

See More

52-Week High 31.2900
Fibonacci 61.8% 25.2582
Fibonacci 50% 23.3950
Fibonacci 38.2% 21.5318
Last Price 16.5900
52-Week Low 15.5000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar